Woodline Partners’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-437,000
Closed -$20.5M 1040
2025
Q2
$20.5M Sell
437,000
-1,707,814
-80% -$76M 0.11% 279
2025
Q1
$94.7M Buy
2,144,814
+654,678
+44% +$30.1M 0.62% 18
2024
Q4
$53.8M Buy
1,490,136
+108,512
+8% +$3.79M 0.36% 69
2024
Q3
$44.3M Buy
1,381,624
+19,225
+1% +$718K 0.37% 78
2024
Q2
$51.3M Buy
1,362,399
+495,175
+57% +$20.8M 0.49% 53
2024
Q1
$42.7M Buy
867,224
+65,042
+8% +$3.01M 0.39% 71
2023
Q4
$29.3M Buy
802,182
+610,809
+319% +$15.9M 0.32% 95
2023
Q3
$4.42M Buy
191,373
+44,373
+30% +$1.21M 0.05% 328
2023
Q2
$3.85M Sell
147,000
-1,300,389
-90% -$34.2M 0.05% 335
2023
Q1
$37.3M Buy
+1,447,389
New +$42.3M 0.53% 45
2022
Q2
Sell
-233,210
Closed -$13.2M 885
2022
Q1
$13.2M Sell
233,210
-9,190
-4% -$526K 0.22% 142
2021
Q4
$15M Buy
242,400
+229,074
+1,719% +$15.2M 0.22% 130
2021
Q3
$845K Sell
13,326
-82,132
-86% -$6.33M 0.01% 524
2021
Q2
$7.87M Sell
95,458
-79,870
-46% -$6.06M 0.15% 165
2021
Q1
$12.9M Buy
175,328
+45,496
+35% +$3.56M 0.29% 94
2020
Q4
$9.41M Sell
129,832
-92,544
-42% -$5.96M 0.25% 120
2020
Q3
$10.6M Buy
222,376
+59,861
+37% +$2.55M 0.35% 82
2020
Q2
$6.83M Sell
162,515
-48,378
-23% -$1.72M 0.27% 92
2020
Q1
$5.69M Buy
+210,893
New +$6.88M 0.41% 77

Other funds holding SWTX